Contineum Therapeutics, Inc.
CTNM
$14.19
-$1.11-7.26%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 236.55M | 246.33M | 262.90M | 182.41M | 175.48M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 6.03M | 6.64M | 5.02M | 2.52M | 1.36M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 242.58M | 252.96M | 267.92M | 184.93M | 176.84M |
|
|
|||||
| Total Current Assets | 242.58M | 252.96M | 267.92M | 184.93M | 176.84M |
| Net Property, Plant & Equipment | 7.42M | 8.07M | 8.47M | 5.65M | 5.86M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 364.00K | 312.00K | 256.00K | 266.00K | 186.00K |
| Total Assets | 250.37M | 261.35M | 276.64M | 190.85M | 182.89M |
|
|
|||||
| Total Accounts Payable | 505.00K | 1.50M | 1.02M | 786.00K | 2.00M |
| Total Accrued Expenses | 3.63M | 2.86M | 6.39M | 4.10M | 3.75M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.39M | 2.30M | 2.34M | 1.48M | 1.47M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 6.53M | 6.66M | 9.74M | 6.36M | 7.21M |
|
|
|||||
| Total Current Liabilities | 6.53M | 6.66M | 9.74M | 6.36M | 7.21M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 4.18M | 4.65M | 5.91M | 4.02M | 4.28M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 10.71M | 11.31M | 15.65M | 10.38M | 11.50M |
|
|
|||||
| Common Stock & APIC | 447.22M | 442.13M | 438.11M | 342.43M | 320.68M |
| Retained Earnings | -206.99M | -191.84M | -177.38M | -162.22M | -149.43M |
| Treasury Stock & Other | -573.00K | -253.00K | 260.00K | 265.00K | 147.00K |
| Total Common Equity | 239.66M | 250.04M | 260.99M | 180.47M | 171.39M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 239.66M | 250.04M | 260.99M | 180.47M | 171.39M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 239.66M | 250.04M | 260.99M | 180.47M | 171.39M |
|
|
|||||